Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Genome Sequence of the Atypical Symbiotic Frankia R43 Strain, a Nitrogen-Fixing and Hydrogen-Producing Actinobacterium.

Pujic P, Bolotin A, Fournier P, Sorokin A, Lapidus A, Richau KH, Briolay J, Mebarki F, Normand P, Sellstedt A.

Genome Announc. 2015 Nov 25;3(6). pii: e01387-15. doi: 10.1128/genomeA.01387-15.

2.

Partial androgen insensitivity with phenotypic variation caused by androgen receptor mutations that disrupt activation function 2 and the NH(2)- and carboxyl-terminal interaction.

Quigley CA, Tan JA, He B, Zhou ZX, Mebarki F, Morel Y, Forest MG, Chatelain P, Ritzén EM, French FS, Wilson EM.

Mech Ageing Dev. 2004 Oct-Nov;125(10-11):683-95.

PMID:
15541764
3.

New insight into the molecular basis of 3beta-hydroxysteroid dehydrogenase deficiency: identification of eight mutations in the HSD3B2 gene eleven patients from seven new families and comparison of the functional properties of twenty-five mutant enzymes.

Moisan AM, Ricketts ML, Tardy V, Desrochers M, Mébarki F, Chaussain JL, Cabrol S, Raux-Demay MC, Forest MG, Sippell WG, Peter M, Morel Y, Simard J.

J Clin Endocrinol Metab. 1999 Dec;84(12):4410-25.

PMID:
10599696
4.
5.

Molecular biology and genetics of the 3 beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase gene family.

Simard J, Durocher F, Mébarki F, Turgeon C, Sanchez R, Labrie Y, Couet J, Trudel C, Rhéaume E, Morel Y, Luu-The V, Labrie F.

J Endocrinol. 1996 Sep;150 Suppl:S189-207. Review. No abstract available.

PMID:
8943802
6.

Different phenotypes in a family with androgen insensitivity caused by the same M780I point mutation in the androgen receptor gene.

Rodien P, Mebarki F, Mowszowicz I, Chaussain JL, Young J, Morel Y, Schaison G.

J Clin Endocrinol Metab. 1996 Aug;81(8):2994-8.

PMID:
8768864
7.

Structure-function relationships and molecular genetics of the 3 beta-hydroxysteroid dehydrogenase gene family.

Simard J, Sanchez R, Durocher F, Rhéaume E, Turgeon C, Labrie Y, Luu-The V, Mebarki F, Morel Y, de Launoit Y, et al.

J Steroid Biochem Mol Biol. 1995 Dec;55(5-6):489-505.

PMID:
8547174
8.

Androgens inhibit the proliferation of a variant of the human prostate cancer cell line LNCaP.

Joly-Pharaboz MO, Soave MC, Nicolas B, Mebarki F, Renaud M, Foury O, Morel Y, Andre JG.

J Steroid Biochem Mol Biol. 1995 Oct;55(1):67-76.

PMID:
7577722
9.

Nonsalt-losing male pseudohermaphroditism due to the novel homozygous N100S mutation in the type II 3 beta-hydroxysteroid dehydrogenase gene.

Mébarki F, Sanchez R, Rhéaume E, Laflamme N, Simard J, Forest MG, Bey-Omar F, David M, Labrie F, Morel Y.

J Clin Endocrinol Metab. 1995 Jul;80(7):2127-34.

PMID:
7608265
10.

Molecular basis of human 3 beta-hydroxysteroid dehydrogenase deficiency.

Simard J, Rheaume E, Mebarki F, Sanchez R, New MI, Morel Y, Labrie F.

J Steroid Biochem Mol Biol. 1995 Jun;53(1-6):127-38. Review.

PMID:
7626445
11.
12.

Anti-müllerian hormone in children with androgen insensitivity.

Rey R, Mebarki F, Forest MG, Mowszowicz I, Cate RL, Morel Y, Chaussain JL, Josso N.

J Clin Endocrinol Metab. 1994 Oct;79(4):960-4.

PMID:
7962305
13.

Functional characterization of the novel L108W and P186L mutations detected in the type II 3 beta-hydroxysteroid dehydrogenase gene of a male pseudohermaphrodite with congenital adrenal hyperplasia.

Sanchez R, Mébarki F, Rhéaume E, Laflamme N, Forest MG, Bey-Omard F, David M, Morel Y, Labrie F, Simard J.

Hum Mol Genet. 1994 Sep;3(9):1639-45.

PMID:
7833923
14.
15.

Congenital adrenal hyperplasia due to point mutations in the type II 3 beta-hydroxysteroid dehydrogenase gene.

Rhéaume E, Simard J, Morel Y, Mebarki F, Zachmann M, Forest MG, New MI, Labrie F.

Nat Genet. 1992 Jul;1(4):239-45.

PMID:
1363812
16.

[Androgen receptor. From molecular biology to clinics].

Morel Y, Mebarki F.

Rev Prat. 1992 Jun 15;42(12):1527-33. Review. French. No abstract available.

PMID:
1411179

Supplemental Content

Loading ...
Support Center